Precision Nutrition 4.0: A Big Data and Ethics Foresight Analysis-Convergence of Agrigenomics, Nutrigenomics, Nutriproteomics, and Nutrimetabolomics

OMICS A Journal of Integrative Biology

Volumn 20, Issue 2, 2016, Pages 69-75

  Özdemir, Vural ^a,b,c   Kolker, Eugene ^c,d,e,f  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b AMRITA UNIVERSITY   (India)

^c Data Enabled Life Sciences Alliance International DELSA Global   (United States)

^d CDO Analytics   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGRIGENOMICS; BIOMEDICINE; ECOSYSTEM; GENOMICS; HEALTH STATUS; HUMAN; MEDICAL ETHICS; MEDICAL RESEARCH; METABOLOMICS; NUTRIENT; NUTRIGENOMICS; NUTRIMETABOLOMIC; NUTRIPROTEOMIC; NUTRITION; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SCIENCE; SOCIAL ASPECT; TECHNOLOGY; DIET; PERSONALIZED MEDICINE;

DIET; HUMANS; METABOLOMICS; NUTRIGENOMICS; PRECISION MEDICINE; PROTEOMICS;

EID: 84958605333     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2015.0193     Document Type: Review

References (28)

1. Birch K, and Tyfield D. (2013) Theorizing the bioeconomy: Biovalue, biocapital, bioeconomics or.what? Sci Technol Human Values 38, 299-327.
2. Brewer GJ. (1971). Annotation: Human ecology, an expanding role for the human geneticist. Am J Hum Genet 23, 92-94.
3. Camp KM, and Trujillo E. (2014). Position of the Academy of Nutrition and Dietetics: nutritional genomics. J Acad Nutr Diet 114, 299-312.
4. De Vries R. (2004). How can we help? From sociology in bioethics to sociology of bioethics. J Law Med Ethics 32, 279-292.
5. ElRakaiby M, Dutilh BE, Rizkallah MR, Boleij A, Cole JN, and Aziz RK. (2014). Pharmacomicrobiomics: The impact of human microbiome variations on systems pharmacology and personalized therapeutics. OMICS 18, 402-414.
6. Ferguson LR. (2016). The value of nutrigenomics science. OMICS 20(2) (in press).
7. Kalow W. (2001). Pharmacogenetics in perspective. Drug Metab Dispos 4, 468-470.
8. Kolker E, Janko I, Montague E, et al. (2015). Finding textsupported gene-To-disease co-Appearances with MOPEDDigger. OMICS 19, 754-756.
9. Koster J, Stewart E, and Kolker E. (2016). Health care transformation: A strategy rooted in data and analytics. Acad Med 91(2) (in press).
10. Lanara Z, Giannopoulou E, Fullen M, et al. (2013). Comparative study and meta-Analysis of meta-Analysis studies for the correlation of genomic markers with early cancer detection. Hum Genomics 7, 14.
11. Law J. (2004). After Method. Mess in Social Science Research. Routledge: New York, NY, USA.
12. López JL, and Lunau J. (2012). ELSIfication in Canada: Legal modes of reasoning. Sci Culture 21, 77-99.
13. Nowotny H, Scott P, and Gibbons M. (2003). Mode 2 revisited: The new production of knowledge. Minerva 41, 179-194.
14. Ostrom E. (1990). Governing the Commons: The Evolution of Institutions for Collective Action. Cambridge, United Kingdom: Cambridge University Press.
15. Ostrom E. (1999). Coping with tragedies of the commons. Ann Rev Polit Sci 2, 493-535.
16. Ozdemir V, Suarez-Kurtz G, Stenne R, Somogyi AA, Someya T, Kayaalp SO, and Kolker E. (2009). Risk assessment and communication tools for genotype associations with multifactorial phenotypes: The concept of edge effect and cultivating an ethical bridge between omics innovations and society. OMICS 13, 43-61.
17. Ozdemir V, Endrenyi L, Aynacioglu S, et al. (2014). Bernard Lerer: Recipient of the 2014 inaugural Werner Kalow Responsible Innovation Prize in Global Omics and Personalized Medicine (Pacific Rim Association for Clinical Pharmacogenetics). OMICS 18, 211-221.
18. Ozdemir V, Dove ES, Gürsoy UK, et al. (2016). Personalized medicine beyond genomics: Alternative futures in Big Data-Proteomics, environtome and the social proteome. J Neural Transm (DOI: 10.1007/s00702-015-1489-y)
19. Patrinos GP, Baker DJ, Al-Mulla F, Vasiliou V, and Cooper DN. (2013). Genetic tests obtainable through pharmacies: The good, the bad, and the ugly. Hum Genomics 7, 17.
20. Pavlidis C, Lanara Z, Balasopoulou A, Nebel JC, Katsila T, and Patrinos GP. (2015). Meta-Analysis of genes in commercially available nutrigenomic tests denotes lack of association with dietary intake and nutrient-related pathologies. OMICS 19, 512-520.
21. Pavlidis C, Nebel J-C, Katsila T, and Patrinos GP. (2016). Nutrigenomics 2.0: The need for ongoing and independent evaluation and synthesis of commercial nutrigenomics tests scientific knowledgebase for responsible innovation. OMICS 20(2) (in press).
22. Petersen A. (2013). From bioethics to a sociology of bioknowledge. Soc Sci Med 98, 264-270.
23. Pors F. (2007). The Perils of Prediction. The Economist, July 15.
24. Sauer S, and Luge T. (2015). Nutriproteomics: Facts, concepts, and perspectives. Proteomics 15, 997-1013.
25. Sclove RE. (1989). From alchemy to atomic war: Frederick Soddys Technology Assessment of Atomic Energy, 1900-1915. Sci Technol Human Values 14, 163-194.
26. Thoreau F, and Delvenne P. (2012). Have STS fallen into a political void? Depoliticisation and engagement in the case of nanotechnologies. Politica Sociedade 11, 205-226.
27. WilliamsR. (2006).Compressed foresight and narrative bias: Pitfalls in assessing high technology futures. Sci Culture 15, 327-348.
28. Zeevi D, Korem T, Zmora N, et al. (2015). Personalized nutrition by prediction of glycemic responses. Cell 163, 1079-1094.